Strength Seen in Oportun Financial (OPRT): Can Its 8.6% Jump Turn into More Strength?
Oportun extended its gains for the third consecutive session, climbing higher yesterday after the company issued a letter to shareholders reaffirming its support for CEO Raul Vazquez. In the letter, Oportun urged investors to vote in favor of retaining Vazquez on the board, countering efforts by Findell Capital Management to oust him. The show of confidence in the CEO appeared to boost investor sentiment, pushing OPRT stock higher.
This company is expected to post quarterly earnings of $0.21 per share in its upcoming report, which represents a year-over-year change of +162.5%. Revenues are expected to be $239.79 million, down 4.2% from the year-ago quarter.
While earnings and revenue growth expectations are important in evaluating the potential strength in a stock, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For Oportun Financial, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on OPRT going forward to see if this recent jump can turn into more strength down the road.
The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Oportun Financial belongs to the Zacks Financial - Miscellaneous Services industry. Another stock from the same industry, StepStone Group Inc. (STEP), closed the last trading session 0.1% higher at $57.08. Over the past month, STEP has returned -1.8%.
For StepStone Group, the consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.41. This represents a change of -14.6% from what the company reported a year ago. StepStone Group currently has a Zacks Rank of #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Oportun Financial Corporation (OPRT) : Free Stock Analysis Report
StepStone Group Inc. (STEP) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 days ago
- Yahoo
Why Oscar Health, Inc. (OSCR) Outpaced the Stock Market Today
In the latest trading session, Oscar Health, Inc. (OSCR) closed at $14.45, marking a +1.76% move from the previous day. This change outpaced the S&P 500's 0.4% gain on the day. Meanwhile, the Dow gained 0.47%, and the Nasdaq, a tech-heavy index, added 0.24%. The company's stock has dropped by 30.66% in the past month, falling short of the Finance sector's gain of 3.3% and the S&P 500's gain of 4.61%. The upcoming earnings release of Oscar Health, Inc. will be of great interest to investors. The company's earnings report is expected on August 6, 2025. The company is expected to report EPS of -$0.59, down 395% from the prior-year quarter. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $2.89 billion, up 30.15% from the year-ago period. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.68 per share and revenue of $11.87 billion. These totals would mark changes of -780% and +29.34%, respectively, from last year. Investors might also notice recent changes to analyst estimates for Oscar Health, Inc. Recent revisions tend to reflect the latest near-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 211.41% downward. Right now, Oscar Health, Inc. possesses a Zacks Rank of #4 (Sell). The Insurance - Multi line industry is part of the Finance sector. This group has a Zacks Industry Rank of 159, putting it in the bottom 36% of all 250+ industries. The Zacks Industry Rank is ordered from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Keep in mind to rely on to watch all these stock-impacting metrics, and more, in the succeeding trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Oscar Health, Inc. (OSCR) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤
Yahoo
2 days ago
- Yahoo
Jefferies (JEF) Up 1.7% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Jefferies (JEF). Shares have added about 1.7% in that time frame, underperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Jefferies due for a pullback? Well, first let's take a quick look at its most recent earnings report in order to get a better handle on the recent drivers for Jefferies Financial Group Inc. before we dive into how investors and analysts have reacted as of late. Jefferies Q2 Earnings Meet Estimates on Solid Equity Trading Jefferies' second-quarter fiscal 2025 (ended May 31) adjusted earnings of 43 cents per share matched the Zacks Consensus Estimate. The bottom line compared unfavorably with the prior-year quarter's earnings of 67 cents per were aided by strong equity trading performance. However, weak performances in the IB and asset management businesses, alongside higher expenses, remain a spoilsport. Net income attributable to common shareholders (GAAP basis) was $88 million, declining from $145.7 million in the prior-year quarter. Jefferies' Revenues Decline, Expenses Rise Quarterly net revenues were $1.63 billion, down 1.3% year over year. The top line surpassed the Zacks Consensus Estimate of $1.56 non-interest expenses were $1.50 billion, up 5% from the prior-year quarter. The rise was due to an increase in almost all cost components except compensation and benefits and underwriting of May 31, 2025, book value per common share was $49.96, up from $46.57 as of May 31, 2024. Further, adjusted tangible book value per fully diluted share of $32.84 increased from $31.27. Jefferies's Quarterly Segment Performance Investment Banking and Capital Markets: Net revenues were $1.47 billion, falling 1.6% from the prior-year quarter. The decline was due to subdued equity & debt underwriting and fixed-income trading performance in capital markets, partially offset by a robust performance in equities trading Management: Net revenues were $154.6 million, down 1.2% from the year-ago quarter. How Have Estimates Been Moving Since Then? In the past month, investors have witnessed a flat trend in estimates review. The consensus estimate has shifted -11.36% due to these changes. VGM Scores At this time, Jefferies has a poor Growth Score of F, a score with the same score on the momentum front. Charting a somewhat similar path, the stock has a grade of D on the value side, putting it in the bottom 40% for this investment strategy. Overall, the stock has an aggregate VGM Score of F. If you aren't focused on one strategy, this score is the one you should be interested in. Outlook Jefferies has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Jefferies Financial Group Inc. (JEF) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
2 days ago
- Yahoo
Sallie Mae Q2 Earnings Miss Estimates, Expenses & Provisions Rise Y/Y
Sallie Mae SLM reported second-quarter 2025 earnings per share (EPS) of 32 cents, which missed the Zacks Consensus Estimate of 49 cents. The bottom line declined from the prior-year quarter's EPS of $1.11. The quarterly results were affected by higher provisions for credit losses, a fall in non-interest income and a rise in expenses. Nonetheless, a rise in net interest income (NII) was positive. The company's GAAP net income was $71 million compared with $252 million in the prior-year quarter. Sallie Mae's NII & Expenses Rise Second-quarter NII totaled $376.8 million, up 1.2% year over year. The reported figure beat the Zacks Consensus Estimate by 0.5%. The quarterly net interest margin was 5.31%, which shrank 5 basis points from the prior-year quarter. Non-interest income amounted to $26.8 million, down from $141.8 million in the year-ago quarter. Non-interest expenses rose 5.5% year over year to $167.2 million. SLM's Credit Quality Deteriorates Provision for credit losses was $148.7 million, up from $16.8 million in the prior-year quarter. Net charge-offs for private education loans were $94 million, up 17.5% year over year. Private education loans held for investment net charge-offs, as a percentage of average private education loans held for investment in repayment (annualized), were 2.36%. The figure expanded 17 basis points year over year. Sallie Mae's Balance Sheet Position Improves As of June 30, 2025, deposits were $20.5 billion, up 2% sequentially. Private education loans held for investment were $21.2 billion, up 14.8% from the prior-year quarter. In the reported quarter, the company's private education loan originations declined marginally from the year-ago quarter to $686 million. SLM's Share Repurchase Update In the second quarter, SLM repurchased 2.4 million shares for $70 million under its 2024 share buyback program. Sallie Mae's 2025 Outlook Reaffirmed The company expects diluted earnings per share of $3.00-$3.10. SLM anticipates total loan portfolio net charge-offs as a percentage of average loans in repayment of 2-2.2%. Private education loan originations are expected to grow 6-8% year over year. SLM's non-interest expenses are expected to be $655-$675 million. Final Thoughts on SLM Sallie Mae's overall financial performance seems decent. Robust loan origination and a rise in net interest income are encouraging. However, a rise in provisions for credit losses is a major near-term headwind. SLM Corporation Price, Consensus and EPS Surprise SLM Corporation price-consensus-eps-surprise-chart | SLM Corporation Quote Currently, SLM carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here. Performances of Other Banks Hancock Whitney Corp.'s HWC second-quarter 2025 adjusted earnings per share of $1.37 exceeded the Zacks Consensus Estimate of $1.34. The bottom line rose 4.6% from the prior-year quarter. HWC's results benefited from an increase in non-interest income and NII. Also, higher loans were another positive. However, higher adjusted expenses and provisions alongside lower deposit balances were headwinds. Bank OZK's OZK second-quarter 2025 earnings per share of $1.58 surpassed the Zacks Consensus Estimate of $1.51. Moreover, the bottom line reflected a rise of 3.9% from the prior-year quarter's actual. Overall, OZK's results benefited from a rise in NII and non-interest income, and lower provisions. Also, higher loans and deposit balances were other positives. However, higher non-interest expenses acted as spoilsports. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report SLM Corporation (SLM) : Free Stock Analysis Report Hancock Whitney Corporation (HWC) : Free Stock Analysis Report Bank OZK (OZK) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
